Topical 0.1% Sirolimus

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
278	巨大リンパ管奇形（頚部顔面病変）	2

278. 巨大リンパ管奇形（頚部顔面病変）

臨床試験数 : 19 / 薬物数 : 22 - (DrugBank : 7) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 63

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03972592 (ClinicalTrials.gov)	June 5, 2019	24/5/2019	Topical Sirolimus in Cutaneous Lymphatic Malformations	0.1% Topical Sirolimusin the Treatment of Cutaneous Microcystic Lymphatic Malformations in Children ...	Vascular Malformations;Lymphatic Malformation	Drug: Topical 0.1% Sirolimus;Drug: Topical Vehicle	University Hospital, Tours	University Hospital, Angers	Recruiting	6 Years	N/A	All	55	Phase 2	France
2	EUCTR2018-001359-11-FR (EUCTR)	22/02/2019	23/07/2018	0.1% topical sirolimusin the treatment of cutaneous microcystic lymphatic malformations in children ...	0.1% topical sirolimusin the treatment of cutaneous microcystic lymphatic malformations in children ...	Cutaneous microcystic lymphatic malformations (CMLM) in children and adults MedDRA version: 20.0;Lev ...	Product Name: Sirolimus 0,1% crème INN or Proposed INN: SIROLIMUS	CHRU TOURS	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	55	Phase 2	France

First Previous1Next Last